Skip to content

Clinical study on the treatment of abdominal obesity with spleen deficiency and dampness-blocking type by comprehensive moxibustion with Huolong Cupping

Clinical study on the treatment of abdominal obesity with spleen deficiency and dampness-blocking type by comprehensive moxibustion with Huolong Cupping

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000265
Enrollment
Unknown
Registered
2024-08-20
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

treatment group:Lifestyle intervention+abdominal Huolong Cupping therapy
Control group:Lifestyle intervention

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria of Western medicine and Chinese medicine; 2) Age =18 years old and =60 years old, can cooperate with treatment, observation and examination; 3) Informed consent to participate in the study voluntarily.

Exclusion criteria

Exclusion criteria: 1) Alcoholism, pregnancy, lactation, abnormal coagulation mechanism; 2) Secondary obesity caused by other causes: hypothalamic and pituitary diseases, hypothyroidism, increased cortisol, increased insulin, gonadal secretion changes, water retention obesity, hereditary obesity syndrome and drug-induced obesity; 3) Patients with cardiovascular and cerebrovascular diseases, infectious diseases, diabetes, liver, kidney and hematopoietic system and other serious primary diseases, mental patients; 4) Patients who have received weight loss drugs or any other weight loss treatment within 3 months prior to treatment; 5) Patients who received lipid-lowering drugs within 3 months before treatment; 6) Allergic to moxa tobacco; 7 Abdominal skin damage, edema or vascular lesions; 8) organic diseases of abdominal organs, such as abdominal tumors, hemangiomas, etc.

Design outcomes

Primary

MeasureTime frame
BMI, waist circumference, weight (4, 8 weeks);

Secondary

MeasureTime frame
Fat rate and obesity score of spleen deficiency and damp retention type (4,8 weeks);TC\TG\HDL-C\LDL-C\?HDL-C;

Countries

China

Contacts

Public ContactChenZhenzhen

Guangdong Provincial Hospital of Chinese medicine

568936184@qq.com15102005159

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026